A new vaccine against HIV, to be tested in a trial to be launched in South Africa Wednesday, could be “the final nail in the coffin” for the disease if it is successful, scientists say. The study, called HVTN 702, aims to enroll 5,400 sexually active men and women aged between 18 and 35 at ...
↧